UK Tribunal Overturns £89M Epilepsy Drug Pricing Fine
A U.K. appeals tribunal on Thursday sent a case accusing Pfizer and Flynn Pharma of charging the National Health Service excessive and unfair prices for an anti-epilepsy drug back to the...To view the full article, register now.
Already a subscriber? Click here to view full article